Dr. Jorge Abreu Vicente commited on
Commit
a5f0bc1
1 Parent(s): 2c1eb68

Update README.md

Browse files
Files changed (1) hide show
  1. README.md +39 -40
README.md CHANGED
@@ -59,9 +59,9 @@ task_ids:
59
 
60
  ## Dataset Description
61
 
62
- - **Homepage: https://microsoft.github.io/BLURB/index.html**
63
- - **Paper: [Domain-Specific Language Model Pretraining for Biomedical Natural Language Processing](https://arxiv.org/pdf/2007.15779.pdf)**
64
- - **Leaderboard: https://microsoft.github.io/BLURB/leaderboard.html**
65
  - **Point of Contact:**
66
 
67
  ### Dataset Summary
@@ -108,33 +108,32 @@ in a sentence by giving its start and end characters.
108
  As before, the training set consists of a set of sentences,
109
  and for each sentence a set of gene mentions
110
  (GENE annotations).
111
- - **Homepage: ** https://biocreative.bioinformatics.udel.edu/tasks/biocreative-ii/task-1a-gene-mention-tagging/
112
  - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
113
- - **Paper: ** [verview of BioCreative II gene mention recognition](https://link.springer.com/article/10.1186/gb-2008-9-s2-s2)
114
 
115
  #### NCBI Disease
116
 
117
  The NCBI disease corpus is fully annotated at the mention
118
  and concept level to serve as a research resource for the biomedical natural
119
  language processing community.
120
- Corpus Characteristics
121
- ----------------------
122
- * 793 PubMed abstracts
123
- * 6,892 disease mentions
124
- * 790 unique disease concepts
125
- * Medical Subject Headings (MeSH®)
126
- * Online Mendelian Inheritance in Man (OMIM®)
127
- * 91% of the mentions map to a single disease concept
128
- **divided into training, developing and testing sets.
129
- Corpus Annotation
130
- * Fourteen annotators
131
- * Two-annotators per document (randomly paired)
132
- * Three annotation phases
133
- * Checked for corpus-wide consistency of annotations
134
-
135
- - **Homepage: ** https://www.ncbi.nlm.nih.gov/CBBresearch/Dogan/DISEASE/
136
  - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
137
- - **Paper: ** [NCBI disease corpus: a resource for disease name recognition and concept normalization](https://pubmed.ncbi.nlm.nih.gov/24393765/)
138
 
139
  #### JNLPBA
140
  The BioNLP / JNLPBA Shared Task 2004 involves the identification
@@ -149,25 +148,25 @@ Sentences are separated by blank lines.
149
  - **Paper: ** [Introduction to the Bio-entity Recognition Task at JNLPBA](https://aclanthology.org/W04-1213)
150
 
151
  #### EBM PICO
152
- - **Homepage: **
153
  - **Repository:**
154
- - **Paper: **
155
- - **Leaderboard: **
156
 
157
  #### ChemProt
158
- - **Homepage: **
159
  - **Repository:**
160
- - **Paper: **
161
 
162
  #### DDI
163
- - **Homepage: **
164
  - **Repository:**
165
- - **Paper: **
166
 
167
  #### GAD
168
- - **Homepage: **
169
  - **Repository:**
170
- - **Paper: **
171
 
172
  #### BIOSSES
173
 
@@ -185,25 +184,25 @@ The sentence pairs were evaluated by five different human experts that judged th
185
  - **Point of Contact:** [Gizem Soğancıoğlu]([email protected]) and [Arzucan Özgür]([email protected])
186
 
187
  #### HoC
188
- - **Homepage: **
189
  - **Repository:**
190
- - **Paper: **
191
- - **Leaderboard: **
192
  - **Point of Contact:**
193
 
194
 
195
  #### PubMedQA
196
- - **Homepage: **
197
  - **Repository:**
198
- - **Paper: **
199
- - **Leaderboard: **
200
  - **Point of Contact:**
201
 
202
  #### BioASQ
203
- - **Homepage: **
204
  - **Repository:**
205
- - **Paper: **
206
- - **Leaderboard: **
207
  - **Point of Contact:**
208
 
209
  ### Supported Tasks and Leaderboards
 
59
 
60
  ## Dataset Description
61
 
62
+ - **Homepage:** https://microsoft.github.io/BLURB/index.html
63
+ - **Paper:** [Domain-Specific Language Model Pretraining for Biomedical Natural Language Processing](https://arxiv.org/pdf/2007.15779.pdf)
64
+ - **Leaderboard:** https://microsoft.github.io/BLURB/leaderboard.html
65
  - **Point of Contact:**
66
 
67
  ### Dataset Summary
 
108
  As before, the training set consists of a set of sentences,
109
  and for each sentence a set of gene mentions
110
  (GENE annotations).
111
+ - **Homepage:** https://biocreative.bioinformatics.udel.edu/tasks/biocreative-ii/task-1a-gene-mention-tagging/
112
  - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
113
+ - **Paper:** [verview of BioCreative II gene mention recognition](https://link.springer.com/article/10.1186/gb-2008-9-s2-s2)
114
 
115
  #### NCBI Disease
116
 
117
  The NCBI disease corpus is fully annotated at the mention
118
  and concept level to serve as a research resource for the biomedical natural
119
  language processing community.
120
+ Corpus Characteristics
121
+ ----------------------
122
+ * 793 PubMed abstracts
123
+ * 6,892 disease mentions
124
+ * 790 unique disease concepts
125
+ * Medical Subject Headings (MeSH®)
126
+ * Online Mendelian Inheritance in Man (OMIM®)
127
+ * 91% of the mentions map to a single disease concept
128
+ **divided into training, developing and testing sets.
129
+ Corpus Annotation
130
+ * Fourteen annotators
131
+ * Two-annotators per document (randomly paired)
132
+ * Three annotation phases
133
+ * Checked for corpus-wide consistency of annotations
134
+ - **Homepage:** https://www.ncbi.nlm.nih.gov/CBBresearch/Dogan/DISEASE/
 
135
  - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
136
+ - **Paper:** [NCBI disease corpus: a resource for disease name recognition and concept normalization](https://pubmed.ncbi.nlm.nih.gov/24393765/)
137
 
138
  #### JNLPBA
139
  The BioNLP / JNLPBA Shared Task 2004 involves the identification
 
148
  - **Paper: ** [Introduction to the Bio-entity Recognition Task at JNLPBA](https://aclanthology.org/W04-1213)
149
 
150
  #### EBM PICO
151
+ - **Homepage:**
152
  - **Repository:**
153
+ - **Paper:**
154
+ - **Leaderboard:**
155
 
156
  #### ChemProt
157
+ - **Homepage:**
158
  - **Repository:**
159
+ - **Paper:**
160
 
161
  #### DDI
162
+ - **Homepage:**
163
  - **Repository:**
164
+ - **Paper:**
165
 
166
  #### GAD
167
+ - **Homepage:**
168
  - **Repository:**
169
+ - **Paper:**
170
 
171
  #### BIOSSES
172
 
 
184
  - **Point of Contact:** [Gizem Soğancıoğlu]([email protected]) and [Arzucan Özgür]([email protected])
185
 
186
  #### HoC
187
+ - **Homepage:**
188
  - **Repository:**
189
+ - **Paper:**
190
+ - **Leaderboard:**
191
  - **Point of Contact:**
192
 
193
 
194
  #### PubMedQA
195
+ - **Homepage:**
196
  - **Repository:**
197
+ - **Paper:**
198
+ - **Leaderboard:**
199
  - **Point of Contact:**
200
 
201
  #### BioASQ
202
+ - **Homepage:**
203
  - **Repository:**
204
+ - **Paper:**
205
+ - **Leaderboard:**
206
  - **Point of Contact:**
207
 
208
  ### Supported Tasks and Leaderboards